Abstract
The presence and clinical evolution of coronary atherosclerosis depend on various classic risk factors and biomarkers. However, the search for more specific markers is necessary, especially for individuals with non-obstructive coronary artery disease, lesions < 50%. In this regard, the field of plasma proteomics could enable the discovery of these novel biological indicators.To evaluate a…